Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 20;13(1):6501.
doi: 10.1038/s41598-023-33116-z.

Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos

Giulia Di Mauro #  1 , Francesca Frontini #  1 , Elena Torreggiani #  1 , Maria Rosa Iaquinta  1 , Andrea Caselli  1 , Chiara Mazziotta  1 , Valentina Esposito  1 , Elisa Mazzoni  2 , Roberta Libener  3 , Federica Grosso  4 , Antonio Maconi  3 , Fernanda Martini  1 , Ilaria Bononi #  5 , Mauro Tognon #  6
Affiliations

Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos

Giulia Di Mauro et al. Sci Rep. .

Abstract

The epigenetic role of microRNAs is established at both physiological and pathological levels. Dysregulated miRNAs and their targets appear to be a promising approach for innovative anticancer therapies. In our previous study, circulating miR-197-3p tested dysregulated in workers ex-exposed to asbestos (WEA). Herein, an epigenetic investigation on this circulating miRNA was carried out in sera from malignant pleural mesothelioma (MPM) patients. MiR-197-3p was quantified in MPM (n = 75) sera and comparatively analyzed to WEA (n = 75) and healthy subject (n = 75) sera, using ddPCR and RT-qPCR techniques. Clinicopathological characteristics, occupational, non-occupational information and overall survival (OS) were evaluated in correlation studies. MiR-197-3p levels, analyzed by ddPCR, were significantly higher in MPM than in WEA cohort, with a mean copies/µl of 981.7 and 525.01, respectively. Consistently, RT-qPCR showed higher miR-197-3p levels in sera from MPM with a mean copies/µl of 603.7, compared to WEA with 336.1 copies/µl. OS data were significantly associated with histologic subtype and pleurectomy. Circulating miR-197-3p is proposed as a new potential biomarker for an early diagnosis of the MPM onset. Indeed, miR-197-3p epigenetic investigations along with chest X-ray, computed tomography scan and spirometry could provide relevant information useful to reach an early and effective diagnosis for MPM.

PubMed Disclaimer

Conflict of interest statement

The following authors: G.D.M., F.F., E.T., E.M., R.L., F.M., I.B., and M.T. declare that data from this study has been employed, in part, for the Italian patent application number RBI17430-IT. M.R.I., A.C., C.M., F.G., V.E. declare no conflict of interest.

Figures

Figure 1
Figure 1
MiR-197-3p analysis by ddPCR. (A) WEA and HS cohorts: the amount of miR-197-3p is represented as copies/µl of analyzed cDNA (ANOVA ****P < 0.0001; Tukey’s test: MPM vs WEA **P = 0.0036; WEA vs HS ****P = 0.0001); (B) ROC curve for the comparative analysis of miR-197-3p levels in MPM vs. WEA; (C) ROC curve for the comparative analysis of miR-197-3p levels in MPM vs. HS.
Figure 2
Figure 2
MiR-197-3p analysis by RT-qPCR. (A) WEA and HS cohorts: the amount of miR-197-3p is represented as copies/µl of analyzed cDNA (ANOVA P = ns; Tukey's test: MPM vs WEA P = ns; MPM vs HS P = ns; WEA vs HS P = ns). (B) ROC curve for the comparative analysis of miR-197-3p levels in MPM vs. WEA; (C) ROC curve for the comparative analysis of miR-197-3p levels in MPM vs. HS.
Figure 3
Figure 3
MiR-197-3p levels in MPM histotypes. MiR-197-3p expression detected by RT-qPCR (A) and by ddPCR (B). The amount of miR-197-3p is represented as copies/µl of analyzed cDNA.
Figure 4
Figure 4
Overall survival (OS) outcome analysis at 18 months in MPM cohort. (A) Kaplan–Meier (KM) curves for OS in MPM patients related to miR-197-3p expression revealed by RT-qPCR (log-rank P > 0.05) and (B) ddPCR (log-rank P > 0.05). (C) Kaplan–Meier (KM) curves for OS in MPM patients related to histological subtype (log-rank **P = 0.0056). (D) Kaplan–Meier (KM) curves for OS in MPM patients underwent to pleurectomy (log-rank *P = 0.0394).
See this image and copyright information in PMC

References

    1. Beckett P, et al. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer. 2015;88:344–348. doi: 10.1016/j.lungcan.2015.03.005. - DOI - PubMed
    1. Rossini M, et al. New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Front. Oncol. 2018;8:410. doi: 10.3389/fonc.2018.00091. - DOI - PMC - PubMed
    1. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-asbestos causes. Arch. Pathol. Lab. Med. 2018;142:753–760. doi: 10.5858/arpa.2017-0365-RA. - DOI - PubMed
    1. Rotondo JC, Mazzoni E, Bononi I, Tognon M, Martini F. Association between simian virus 40 and human tumors. Front. Oncol. 2019;9:441. doi: 10.3389/fonc.2019.00670. - DOI - PMC - PubMed
    1. Pass HI, Alimi M, Carbone M, Yang H, Goparaju CM. Mesothelioma biomarkers: Discovery in search of validation. Thorac. Surg. Clin. 2020;30:395–423. doi: 10.1016/j.thorsurg.2020.08.001. - DOI - PubMed

Publication types